Trevi Therapeutics, Inc. SEC filings TRVI
Trevi Therapeutics, Inc. has 537 filings in SEC EDGAR's recent list, going back to Dec 18, 2012. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 6, 2026 | — |
| 424B5 | Prospectus supplement | Apr 17, 2026 | — |
| 424B5 | Prospectus supplement | Apr 16, 2026 | — |
| S-3ASR | Automatic shelf registration | Nov 13, 2025 | — |
| S-8 | Employee stock plan registration | Aug 7, 2025 | — |
| 424B5 | Prospectus supplement | Jun 4, 2025 | — |
| 424B5 | Prospectus supplement | Jun 2, 2025 | — |
| S-8 | Employee stock plan registration | Mar 18, 2025 | — |
| 424B5 | Prospectus supplement | Dec 16, 2024 | — |
| S-8 | Employee stock plan registration | Mar 20, 2024 | — |
| S-3/A | Filing | Aug 11, 2023 | — |
| S-3 | Shelf registration | Jun 29, 2023 | — |
| S-8 | Employee stock plan registration | May 11, 2023 | — |
| 424B5 | Prospectus supplement | Sep 23, 2022 | — |
| 424B5 | Prospectus supplement | Sep 22, 2022 | — |
| 424B5 | Prospectus supplement | May 16, 2022 | — |
| S-8 | Employee stock plan registration | May 2, 2022 | — |
| S-3 | Shelf registration | May 2, 2022 | — |
| S-3 | Shelf registration | Nov 5, 2021 | — |
| S-3 | Shelf registration | Oct 15, 2021 | — |
| S-1 | Registration statement | Aug 27, 2021 | — |
| 424B3 | Prospectus | Jul 14, 2021 | — |
| S-1 | Registration statement | Jul 7, 2021 | — |
| S-8 | Employee stock plan registration | Jul 7, 2021 | — |
| 424B3 | Prospectus | Jul 2, 2020 | — |
| S-3 | Shelf registration | Jun 26, 2020 | — |
| S-8 | Employee stock plan registration | Mar 16, 2020 | — |
| 424B4 | Prospectus | May 8, 2019 | — |
| S-8 | Employee stock plan registration | May 7, 2019 | — |
| FWP | Free writing prospectus | May 7, 2019 | — |
| S-1/A | Amended registration statement | May 7, 2019 | — |
| S-1/A | Amended registration statement | May 6, 2019 | — |
| S-1/A | Amended registration statement | Apr 22, 2019 | — |
| S-1 | Registration statement | Apr 5, 2019 | — |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TRVI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1563880
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.